mine uric acid. It is emphasized that suitable alkalinity increasesthe intensity of the colorwhich develops as a result of reductionof phosphotungstic acid by uric acid to a completely soluble blue complex.
Alkalinity achieved by the use of sodiuni cyanide in the method of Brown (I) imparts considerable advantages, principally a high sensitivity-i.e., tjie color developed has high absorbance, which makes the contribution by interfering chromogens such as L-ascorbicacid and other reducing agents relatively negligible. The use of sodium cyanide has disadvantages: the blank has appreciableabsorbance, the standard curve is not reproducible, and it is highly poisonous. Most laboratories prefer sodium carbonate (2) to produce alkalinity, which makes the method less sensitive than with sodium cyanide, and one still encounters turbidity at the finalcolor development just as with cyanide. Reported modifications (3-7) are not at all satisfactory. The standard curves fail to obey Beer's law, or are linear only up to 15 mg of uric acid per 100 ml, and colorstabilityispoor.
The present study shows how the method in which carbonate is used can be improved by limiting the turbidity-producing salts. Phosphotungstic Dissolve 100 g of anhydrous sodium carbonate, 200 g of urea, and 50 g of triethanolamine in water and dilute to 1 liter. 
Results

Phosphotungstic Acid as a Protein Precipitant
With many of the early methods for determining uric acid, one frequently encounters turbidity. Therefore, we considered the role of the tungstate and sulfate anions present in the more classic precipitating reagents. These anions could be eliminated and the number of reagents reduced by the use of phosphotungstic acid as a protein precipitant.
Effect of Trisodium Phosphate
The serum proteins are completely removed by precipitation with phosphotungstic acid, at a pH of about 4.5. To ensure good recovery of uric acid, is-ascorbic acid and other reducing agents that because the former makes pH control easier and has less deleterious effect on the phosphotungstic acid.
All the non-urate chromogens were eliminated by use of 1 g of trisodium phosphate per 100 ml. A mean value of 4.88 mg of uric acid per 100 ml was obtained on quintuple analyses of a serum sample. The mean value for similar analyses of the same serum sample, to which 300 mg glucose and 6 mg each of i,.ascorbic acid, reduced glutathione, salicylate, gentisic acid, cystine, and tryptophan had been added per 100 ml, was 4.93 mg of uric acid per 100 ml. The difference, 0.05 mg/100 ml, is less than the standard deviation of the proposed method and hence not significant. A stabilizing agent, triethanolamine (5 g/100 ml), was added to this alkaline solution, now termed CUTE. It stabilized the color considerably (Figure 1) . Figure 2 displays the absorbance spectra of the final color, read against the reagent blank. The absorption peak is at 680 nm. The absorption spectrum of the reagent blank, read against water, shows maximum absorbance from 650 to 700 nm (0.2 absorbance units absorbance and concentrationis in fact obtained for concentrations of uric acid up to 20 mg/100 ml or more; this provides a wider range of applicability of the proposed method.
Absorption Spectra and Calibration Curve
Recovery Study
Recovery was measured by analyzing pooled serum to which 0 to 15 mg of uric acid was added per 100 ml. Recovery ranged from 97.2 to 100.0% with a mean of 98.7% (Table 1) .
The precision of the method was tested by 45 analyses of a pooled serum. The results obtained rangedfrom 5.8 to 6.0 mg/100 ml with a mean of 5.9 ± 0.07 SD, and a SE of ± 0.01. Repetitive analyses were made on the pool and groups of Versatols (stated to contain 3, 6, or 8.1 mg of uric acid per 100 ml) to assess the accuracy of the proposed method and to compare it with the uricase (8) method and Brown's (1) method (Table 2) .
Discussion
By eliminating the use of anion-contributing reagents such as tungstate and sulfate, we successfully overcame the problem of turbidity.
The phosphotungstic acid used in the proposed method serves well as a precipitant of serum proteins as well as a color-forming reagent. Some alkalinity is essential to development of an intense blue, but a too-high concentration of alkali occasionally causes unwanted precipitation.
In the proposed method, a sodium carbonate concentration was used (10 g/100 ml) that has a pH of about 11.6; the pH is maintained by the addition of urea, which also improves the sensitivity of the method.
Instability of the color is usual with other methods. Here, triethanolamine keeps the color stable. Triethanolamine in the CUTE reagent provides a stabilizing action (pH is about 10.5 in the final reaction mixture) and also optimizes color development, resulting in a plateau of absorbance at 680 nm that is found between 15 and 50 mm. Interfering reducing agents and other non-urate chromogens, which have been a difficult problem in the uric acid-phosphotungstic acid reaction, have no significant effect on the results obtained by the proposed method.
The precision, accuracy, recovery, and linearity of concentration vs. absorbance over a wide clinical and therapeutic range further testify to the merits and practicability of the proposed method. The accuracy of the present method compares closely with that of the uricase method and Brown's method. The proposed method is in slightlycloser agreement with the uricase method than with Brown's method.
The simplicity, sensitivity, precision, accuracy, stability of reagents, and the amount of specimen required for analysis are all essential criteria in determining the choice of method. The method presented in this paper is the first reported in the literature that satisfies all the above criteria; thus, it is virtually ideal for routine clinical use.
